Brooklyn Investment Group Buys 830 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Brooklyn Investment Group lifted its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) by 21.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,757 shares of the pharmacy operator’s stock after purchasing an additional 830 shares during the quarter. Brooklyn Investment Group’s holdings in Walgreens Boots Alliance were worth $44,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in WBA. First Financial Corp IN boosted its holdings in Walgreens Boots Alliance by 49.2% in the fourth quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock worth $25,000 after acquiring an additional 885 shares in the last quarter. TD Private Client Wealth LLC grew its position in Walgreens Boots Alliance by 8,670.3% in the 3rd quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator’s stock valued at $29,000 after purchasing an additional 3,208 shares during the period. Sentry Investment Management LLC bought a new stake in Walgreens Boots Alliance during the 3rd quarter valued at $30,000. Eastern Bank acquired a new position in Walgreens Boots Alliance during the third quarter worth $33,000. Finally, Strategic Investment Solutions Inc. IL bought a new position in shares of Walgreens Boots Alliance in the second quarter valued at $34,000. 58.59% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on WBA shares. UBS Group upped their target price on shares of Walgreens Boots Alliance from $9.00 to $10.00 and gave the stock a “neutral” rating in a report on Thursday, October 17th. Evercore ISI increased their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a research note on Monday, January 13th. Royal Bank of Canada lifted their target price on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a research report on Wednesday, January 15th. Morgan Stanley dropped their price objective on Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating on the stock in a research note on Friday, October 11th. Finally, Bank of America increased their target price on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a report on Monday, January 13th. Four analysts have rated the stock with a sell rating, nine have issued a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat, Walgreens Boots Alliance currently has an average rating of “Hold” and an average price target of $13.27.

Read Our Latest Analysis on Walgreens Boots Alliance

Walgreens Boots Alliance Stock Performance

NASDAQ:WBA opened at $12.52 on Monday. The company has a market capitalization of $10.81 billion, a P/E ratio of -1.22, a P/E/G ratio of 1.55 and a beta of 0.64. The business has a fifty day simple moving average of $9.57 and a two-hundred day simple moving average of $9.84. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.68 and a quick ratio of 0.37. Walgreens Boots Alliance, Inc. has a 1 year low of $8.08 and a 1 year high of $23.76.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last released its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, beating the consensus estimate of $0.38 by $0.13. The business had revenue of $39.50 billion for the quarter, compared to the consensus estimate of $37.40 billion. Walgreens Boots Alliance had a negative net margin of 5.85% and a positive return on equity of 14.23%. The company’s revenue was up 7.6% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.66 earnings per share. On average, analysts expect that Walgreens Boots Alliance, Inc. will post 1.52 earnings per share for the current year.

Walgreens Boots Alliance Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, December 12th. Shareholders of record on Monday, November 18th were issued a dividend of $0.25 per share. The ex-dividend date of this dividend was Monday, November 18th. This represents a $1.00 dividend on an annualized basis and a yield of 7.99%. Walgreens Boots Alliance’s payout ratio is -9.77%.

Walgreens Boots Alliance Company Profile

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Recommended Stories

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.